Marks Group Wealth Management Inc raised its position in shares of Cigna Group (NYSE:CI - Free Report) by 23.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 27,164 shares of the health services provider's stock after buying an additional 5,141 shares during the quarter. Marks Group Wealth Management Inc's holdings in Cigna Group were worth $8,937,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA lifted its position in Cigna Group by 4.5% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,556,278 shares of the health services provider's stock valued at $3,191,151,000 after buying an additional 501,320 shares during the period. Sanders Capital LLC lifted its position in Cigna Group by 2.0% during the fourth quarter. Sanders Capital LLC now owns 8,054,959 shares of the health services provider's stock valued at $2,224,296,000 after buying an additional 154,420 shares during the period. Geode Capital Management LLC increased its holdings in shares of Cigna Group by 1.7% during the fourth quarter. Geode Capital Management LLC now owns 5,957,180 shares of the health services provider's stock valued at $1,640,878,000 after acquiring an additional 101,737 shares in the last quarter. GQG Partners LLC increased its holdings in shares of Cigna Group by 22.4% during the fourth quarter. GQG Partners LLC now owns 4,021,582 shares of the health services provider's stock valued at $1,110,520,000 after acquiring an additional 737,099 shares in the last quarter. Finally, Norges Bank bought a new position in shares of Cigna Group during the fourth quarter valued at $867,785,000. Hedge funds and other institutional investors own 86.99% of the company's stock.
Cigna Group Price Performance
Shares of NYSE:CI traded down $1.91 during trading on Monday, reaching $301.36. The stock had a trading volume of 277,181 shares, compared to its average volume of 1,735,834. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72. The business has a fifty day moving average price of $317.02 and a 200-day moving average price of $310.83. The stock has a market cap of $80.51 billion, a PE ratio of 16.72, a PEG ratio of 0.90 and a beta of 0.44. Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83.
Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. The firm had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The business's revenue was up 14.4% on a year-over-year basis. During the same period in the previous year, the company posted $6.47 earnings per share. On average, equities analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd were paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date was Tuesday, June 3rd. Cigna Group's dividend payout ratio (DPR) is currently 33.44%.
Analyst Ratings Changes
Several equities analysts have recently weighed in on CI shares. Truist Financial raised their price target on Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a report on Monday, May 12th. Mizuho raised their target price on Cigna Group from $360.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Cowen reissued a "buy" rating on shares of Cigna Group in a research report on Monday, May 5th. Robert W. Baird dropped their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Finally, Piper Sandler raised their target price on Cigna Group from $348.00 to $374.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Two research analysts have rated the stock with a hold rating, sixteen have given a buy rating and three have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Cigna Group has a consensus rating of "Buy" and a consensus price target of $380.39.
Read Our Latest Stock Report on CI
Cigna Group Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
Before you consider Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.
While Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
